Answers are grounded in this paper and cite their sources.
Over the last two decades, the use of adult stem cells in therapy has gained significant momentum. However, stem cells are usually associated with high extraction, expansion and storage costs. This is delaying their approval into clinical practice. By repurposing medical waste tissues for stem cell harvesting, there is an opportunity to extract valuable therapeutic material without incurring additional costs associated with procuring raw materials or handling waste disposal. Harvesting stem cells from discarded tissues is a non-invasive, safe procedure that lowers healthcare costs associated with managing donor site complications. Given the dire need for stem cells in regenerative therapies, it is imperative that necessary advancements are made towards reducing the gap between the supply and the demand of such cells for therapy. The innovative concept of “Upcycled mesenchymal Stem Cells (USCs)” has been proposed to upcycle and repurpose adult mesenchymal stem cells from biowastes. Summary has been presented regarding the regenerative applications, current clinical status, potential benefits and limitations of USC-based therapies.
No takes yet. Share an insight, caveat, or question.
Advani et al. (2025) studied this question.
Synapse has enriched 3 related papers. Consider them for comparative context: